NEWS BLOG

Our research group, the Laboratory Molecular Vectorlogy and Gene Therapy (LMVGT) is part of ADVANTAGE labs (Advanced Disease Modeling, Targeted Drug Discovery and Gene Therapy), Dept. Pharmaceutical and Pharmacological Sciences, group Biomedical Sciences at KU Leuven, Belgium. Our mission is to advance viral vector engineering, technology development, production, and application for rare disease modelling and gene therapy. We work in close partnership with the Leuven Viral Ve

For more information, clic here

This new award has been created to recognise individuals for their outstanding contribution to ESGCT's mission to advance knowledge.

✨ We are pleased to share this exciting opportunity for postdoctoral researchers in advanced therapies. Applications are now open for BEYOND, a Marie Skłodowska-Curie Actions COFUND Postdoctoral Program in Advanced Therapies, co-funded by the European Union. BEYOND will recruit 35 postdoctoral fellows for fully funded 3-year fellowships at leading European research centres:• San Raffaele Telethon Institute for Gene Therpay - SR-Tiget (Italy)• Telethon Institute of Genetic

AMM-Only Project, a Monaco-based association dedicated to advancing research in Duchenne muscular dystrophy (DMD) and related neuromuscular diseases, is pleased to announce the opening of applications for the 2026 edition of the Pioneers Grant Programme. Launched in 2025, the Pioneers Grant Programme was created to accelerate scientific discovery and the development of innovative therapeutic approaches for Duchenne muscular dystrophy and other neuromuscular disorders. The pro

The European Society of Gene & Cell Therapy (ESGCT) is looking for a Public Affairs & Health Policy Lead to establish and drive its European policy and advocacy function. This is a unique opportunity for an experienced public affairs professional to: ✅ Shape policy on advanced therapies across Europe ✅ Engage with EU institutions, regulators and key stakeholders ✅ Develop evidence-based policy positions ✅ Work alongside leading scientists, clinicians and patient communities �

The 9th ESGCT Spring School took place in Coimbra, Portugal from 14-17 April 2026. The Spring School was jointly organised with the the Gene Therapy Center of Excellence Portugal (GeneT). Spring School attendees can log in to their registration portal to access their registration details, event resources and certificates of attendance via the link below.

The University of Coimbra (Portugal) is recruiting a Group Leader / Principal Investigator to join GCure, an ERA Chair project funded by Horizon Europe (GA 101186929), focused on strengthening Europe’s capacity in advanced gene therapy development. The position targets an internationally competitive researcher ready to build an independent research programme in areas such as: Viral vector engineering (AAV, lentiviral vectors) Scalable manufacturing and bioprocessing Quality c

The University of Coimbra (Portugal) is recruiting three Group Leaders to join GeneT – The Gene Therapy Center of Excellence Portugal, a Horizon Europe Teaming for Excellence initiative. The positions target internationally competitive researchers ready to establish independent research programmes in one of the following areas: Cardiovascular & pulmonary genetic disorders Ear & ophthalmic disorders Metabolic/hepatic diseases Immunodeficiencies Haematological disorders Musculo

Join us for the 33rd ESGCT Annual Congress, which takes place in collaboration with DG-GT from 27-30 October 2026 at the Congress Center Hamburg, Germany.

Lund University, Sweden are recruiting three tenure-track Assistant Professors in Immuno-Oncology and Immunotherapy. Assistant professor in Immuno-Oncology and Immune Cell Engineering Assistant professor in Immunotechnology Assistant professor in Experimental Cancer Immunotherapy We are looking for candidates ready to build an internationally competitive research programme at the interface of immune engineering, mechanistic discovery, and clinical translation. The positions a

View Claire's biography below 1. What advice do you wish you had received at both the start and the conclusion of your PhD journey? Be open to change — your original plan might evolve, but the learning along the way is just as valuable. Expect setbacks — it’s is a safe space to make mistakes, so treat them as part of the process, not as failures. The experience is as much about training and developing your skills as it is about producing results. Start writing up before

July 6–9, 2026 | Porto, Portugal | Sheraton Porto Hotel & Spa KEYNOTE SPEAKER Luigi Naldini, MD, PhD

Foundation For Rare Diseases (Fondation Maladies Rares, France) organises an online MOOC on gene and gene-based cell therapies for rare diseases . The course features contributions from leading U.S. and European researchers — including Alain Fischer, Heather Gray Edwards, Alessio Cantore, Zoltan Ivics, Sylvie Odent, Salima Hacein-Bey-Abina, Manuel Gonçalves, Marina Cavazzana, Allison Bradbury, Anne Galy, Chantal Pichon, Claire Booth, Jeffrey Medin , among others — as well a

ESGCT are greatly saddened by the loss of Professor Claudio Bordignon, a pioneer in the gene therapy field, and the first President of the ESGCT.

Last Thursday, the FDA approved the LAD gene therapy developed by Juan A. Bueren and Elena Almarza, in collaboration with the Adrian Thrasher team. This treatment was licensed to Rocket Pharma, who developed the clinical trial and presented it to the FDA. We believe this is terrific news for the gene therapy field and for ESGCT, as all these advances have come from ESGCT members, and the society has played a fundamental role in favouring this collaboration and in the developm

The ForTra gGmbH (the nonprofit subsidiary of the Else Kröner-Fresenius Foundation for research transfer) and the SPARK-BIH team of the National Strategy for Gene- and Cell-Based Therapies cordially invite you to their joint workshop on GCT in Frankfurt/Main. Join ForTra and the SPARK-BIH team of the National Strategy for Gene- and Cell-Based Therapies for an inspiring, forward-looking workshop on Gene and Cell therapy (GCT) – one of the most dynamic fields shaping t

Hosted as part of the AROUND THE WORLD SERIES in collaboration with the Coalition of International Gene Therapy Societies.